A case—control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome

Annals of Neurology

Volumn 38, Issue 2, 1995, Pages 225-230

  van Gool, W A ^a   Evenhuis, H M ^b   van Duijn, C M ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Department of Epidemiology and Biostatistics ^*  (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; ALLELE; ALZHEIMER DISEASE; ARTICLE; DOWN SYNDROME; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; DOWN SYNDROME; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MALE; MIDDLE AGE;

EID: 0029084798     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410380215     Document Type: Article

References (48)

1. A prospective study of Alzheimer disease in Down syndrome
2. Apolipoprotein E affects the rate of Alzheimer disease expression: beta‐amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease
3. Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta‐amyloid‐forming diseases
4. ApoE genotype and Down's syndrome
5. Apolipoprotein E type 4 allele distributions in late‐onset Alzheimer's disease and in other amyloid‐forming diseases
6. The influence of apolipoprotein E isotypes on Alzheimer's disease pathology in 40 cases of Down's syndrome
7. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype
8. Evaluation of a screening instrument for dementia in ageing mentally retarded persons
9. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with hha‐1
10. Apolipoprotein E polymorphism and coronary heart disease
11. Lack of association between apolipoprotein E allele epsilon 4 and sporadic Alzheimer's disease
12. Apolipoprotein E4 allele in a population‐based study of early‐onset Alzheimer's disease
13. Apolipoprotein Eepsilon 4 allele and Alzheimer's disease
14. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late‐onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region
15. ApoE‐epsilon 4 and early‐onset Alzheimer's
16. Apolipoprotein E‐epsilon 4 allele and Alzheimer's discase
17. Association of apolipoprotein E allele epsilon 4 with late‐onset familial and sporadic Alzheimer's disease
18. Apolipoprotein E: high‐avidity binding to beta‐amyloid and increased frequency of type 4 allele in late‐onset familial Alzheimer disease
19. Apolipoprotein E epsilon 4 allele frequency in vascular dementia and Alzheimer's disease
20. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
21. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
22. Protective effect of apo epsilon 2 in Alzheimer's disease. Oxford Project to Investigate Memory and Ageing (OPTIMA)
23. Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals
24. Apolipoprotein E genes in Lewy body and Parkinson's disease
25. Confirmation of the epsilon 4 allele of the apolipoprotein E gene as a risk factor for late‐onset Alzheimer's disease
26. Apolipoprotein E genotype and Alzheimer's disease
27. Apolipoprotein E gene in Parkinson's disease with or without dementia
28. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late‐onset nonfamilial Alzheimer's disease
29. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease
30. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study
31. Dose‐dependent association of apolipoprotein E allele type 4 with late‐onset, sporadic Alzheimer's disease
32. Are the associations between Alzheimer's disease and polymorphisms in the apolipoprotein E and the apolipoprotein CH genes due to linkage disequilibrium?
33. Apolipoprotein E: risk factor for Alzheimer disease
34. Confirmation of association between the ϵ4 allele of apolipoprotein E and Alzheimer's disease
35. Apolipoprotein E polymorphism and Alzheimer's disease
36. Association of the apolipoprotein E type 4 allele with clinical subtypes of autopsyconfirmed Alzheimer disease
37. Apolipoprotein E‐epsilon 4 allele and Alzheimer's disease
38. Protection against Alzheimer's disease with apoE epsilon 2
39. The natural history of dementia in Down's syndrome
40. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid
41. Alzheimer's disease: a central role for amyloid
42. Apolipoprotein E‐4 gene dose in clinically diagnosed Alzheimer's disease: prevalence, plasma cholesterol levels and cerebrovascular change
43. Clinical application of apolipoprotein E genotyping to Alzheimer's disease
44. Diagnosis of Alzheimer's disease by apolipoprotein E genotyping
45. Apolipoprotein Eepsilon 4 allele and Alzheimer's disease
46. Risky apolipoprotein in brain